Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA

Public health guidance

19 March 2015

This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.

Publication file

Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA

English (578.52 KB - PDF)

Related content

Cover of the report: "Evidence brief: Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, TB, viral hepatitis and sexually transmitted infections in the European Union and European Economic Area"

Surveillance and monitoring

Evidence brief: Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, TB, viral hepatitis and sexually transmitted infections in the European Union and European Economic Area

23 April 2025

Cover of the report: "Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, tuberculosis, viral hepatitis and sexually transmitted infections in the EU/EEA"

Surveillance and monitoring

Progress towards reaching the Sustainable Development Goal 3.3 related to HIV, TB, viral hepatitis and sexually transmitted infections in the EU/EEA

23 April 2025

Generic cover CDTR 2024

Surveillance and monitoring

Communicable disease threats report, 22-28 March 2025, week 13

28 March 2025

Share this page